- Posted
- Categories
-
- OpenSAFELY
Help us improve research into COVID-19 Vaccination
Could you help us to improve the research that we are doing into COVID-19 vaccination?
OpenSAFELY is a new secure analytics platform for electronic health records in the NHS, created to deliver urgent results during the global COVID-19 emergency.
OpenSAFELY is a new secure analytics platform for electronic health records in the NHS, created to deliver urgent results during the global COVID-19 emergency. It is now successfully delivering analyses across more than 58 million patients’ full pseudonymised primary care NHS records, with more to follow shortly. All our analytic software is open for security review, scientific review, and re-use. OpenSAFELY uses a new model for enhanced security and timely access to data: we don’t transport large volumes of potentially disclosive pseudonymised patient data outside of the secure environments managed by the electronic health record software company; instead, trusted analysts can run large scale computation across near real-time pseudonymised patient records inside the data centre of the electronic health records software company. This pragmatic and secure approach allowed us to deliver our first analyses in just five weeks from project start.
Find out more about how OpenSAFELY works in this blog or read our papers and other blog posts, follow us on Twitter, or visit the website to find out more.
We explore general practice coding activity associated with the use of online consultation systems in terms of trends, COVID-19 effect, variation and quality.
Status: Published
We describe the impact of the COVID-19 pandemic on blood pressure screening and hypertension management in England.
Status: Published
This paper assessed the content and data quality of the COVID-19 Therapeutics dataset within OpenSAFELY, with a specific focused on therapeutics provided in outpatient settings by CMDUs.
Status: Preprint
This proof-of-principle pharmacovigilance study used Electronic Health Record (EHR) data to examine the safety of sotrovimab, paxlovid and molnupiravir in prehospital treatment of Covid-19
Status: Published
Could you help us to improve the research that we are doing into COVID-19 vaccination?
We’ve launched a new project to understand who received which COVID-19 booster shots, and when, and the impacts of this on health outcomes.
It’s not too late to register for our 2nd Annual OpenSAFELY Symposium, which is happening in London on 25/26 November.
We briefly summarise all the recent big and exciting developments in hospital medicines data.